trans-3-(Benzyloxymethyl)cyclobutyl4-nitrobenzoate, 97%, 1g

5-Amino-2-methylnaphthalen-1-ol, 98%, 250mg

2-Fluoro-4-nitrobenzoic acid, 97.0%, 100g

N-(1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)-5-methyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide, 95+%, 1g

1-(4-Chloro-2-fluorophenyl)-2,2,2-trifluoroethan-1-ol, 98%, 100mg

2-(TETRAHYDROFURAN-2-YL)ETHAN-1-OL, 95.0%, 100mg

9-Methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride dihydrate, 98%, 5g

HMBR, 100mg

Ultrasonic device series-H, 2.6 l, H 30 1 Piece

2-Bromo-3-methylbenzenesulfonamide, 100mg

8-BROMO-2'-DEOXYADENOSINE, 95.0%, 250mg

2-Methylbenzo[d]thiazol-4-amine, 98%, 5g

1-(3,4-Dimethoxyphenyl)-2-(2-methoxyphenoxy)-propane-1,3-diol, 95.0%, 5g